TASP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.295900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.129780E-01
Normal-vs-Stage2
1.026040E-01
Normal-vs-Stage3
1.566330E-02
Normal-vs-Stage4
2.383000E-01
Stage1-vs-Stage2
5.310800E-01
Stage1-vs-Stage3
1.096080E-02
Stage1-vs-Stage4
9.084000E-01
Stage2-vs-Stage3
7.190200E-02
Stage2-vs-Stage4
6.731600E-01
Stage3-vs-Stage4
6.473700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.100800E-01
Normal-vs-AfricanAmerican
5.115900E-02
Normal-vs-Asian
3.417700E-02
Caucasian-vs-AfricanAmerican
5.368200E-01
Caucasian-vs-Asian
2.376600E-01
AfricanAmerican-vs-Asian
7.920000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.494160E-01
Normal-vs-Female
4.396400E-02
Male-vs-Female
5.946600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.964400E-02
Normal-vs-Age(41-60Yrs)
1.770010E-01
Normal-vs-Age(61-80Yrs)
8.553700E-02
Normal-vs-Age(81-100Yrs)
2.009700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.512400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.644800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.332400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.965800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.924100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.031600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.585700E-02
Normal-vs-Daily Drinker
6.500600E-03
Normal-vs-Weekly Drinker
1.184810E-01
Normal-vs-Occasional Drinker
2.308800E-01
Normal-vs-Social Drinker
2.058200E-01
Non Drinker-vs-Daily Drinker
1.419220E-01
Non Drinker-vs-Weekly Drinker
9.648200E-01
Non Drinker-vs-Occasional Drinker
2.188800E-01
Non Drinker-vs-Social Drinker
5.280600E-01
Daily Drinker-vs-Weekly Drinker
2.474400E-01
Daily Drinker-vs-Occasional Drinker
1.031970E-02
Daily Drinker-vs-Social Drinker
6.526200E-02
Weekly Drinker-vs-Occasional Drinker
3.012600E-01
Weekly Drinker-vs-Social Drinker
5.877800E-01
Occasional Drinker-vs-Social Drinker
6.606600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.028200E-01
Normal-vs-Grade 2
7.995800E-02
Normal-vs-Grade 3
9.080000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.522600E-01
Grade 1-vs-Grade 3
2.098600E-01
Grade 1-vs-Grade 4
2.028200E-01
Grade 2-vs-Grade 3
7.148200E-01
Grade 2-vs-Grade 4
7.995800E-02
Grade 3-vs-Grade 4
9.080000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.347900E-02
Normal-vs-NonDiabetic
7.430300E-02
Diabetic-vs-NonDiabetic
1.693430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.580340E-02
Normal-vs-NoPancreatitis
7.869900E-02
Pancreatitis-vs-NoPancreatitis
2.468400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.266000E-02
Normal-vs-N1
1.095240E-01
N0-vs-N1
8.173200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.237400E-01
Normal-vs-TP53-NonMutant
2.004000E-01
TP53-Mutant-vs-TP53-NonMutant
7.876200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
